vimarsana.com
Home
Live Updates
PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake : vimarsana.com
PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake : vimarsana.com
PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake
Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO
Related Keywords
India ,
Venkateswarlu Jasti ,
V Prasada Raju ,
Suven Lifesciences ,
Suven Pharma ,
Sudhir Kumar Singh ,
Abhijit Mukherjee ,
Pankaj Patwari ,
Shweta Jalan ,
Jj Asia Pacific ,
Annaswamy Vaidheesh ,
Prasada Raju ,
Stefan Stoffel ,
Aragen Life Sciences ,
Partner At Advent International ,
Advent International Corporation ,
Organization Of Pharmaceutical Producers India ,
Partners Lps ,
Suven Pharmaceuticals Ltd ,
Cohance Life Sciences ,
Berhyanda Ltd ,
Granules India Ltd ,
Suven Pharmaceuticals ,
Advisory Council ,
Advent International ,
Executive Chairman ,
Managing Director ,
Chief Executive Officer ,
Chairman Annaswamy Vaidheesh ,
Pharmaceutical Producers ,
Granules India ,
Managing Partner ,
Cyprus Based Berhyanda Ltd ,
Advent Funds ,
Limited Partners ,
International Corporation ,
Rivate Equity ,
Dmo ,